Pharmacology, Toxicology and Pharmaceutical Science
Acute Kidney Failure
9%
Adverse Event
20%
Antifungal Agent
19%
Apixaban
19%
Atorvastatin
8%
Atrial Fibrillation
19%
Beers Criteria
9%
Cholinergic Receptor Blocking Agent
39%
Cohort Study
5%
Community Pharmacy
28%
COVID-19 Vaccine
9%
Cross Sectional Study
9%
Cross-Sectional Study
100%
Diabetes Mellitus
11%
Diseases
9%
Drug Interaction
19%
Dyslipidemia
8%
Exposure to Violence
19%
FDA Adverse Event Reporting System
19%
Hemodialysis
19%
Hospital Mortality
9%
Hospital Pharmacy
9%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
19%
Infection
19%
Ixazomib
5%
Low Density Lipoprotein Cholesterol
14%
Lung Disease
9%
Multiple Myeloma
19%
Mycosis
19%
Neurologic Disease
19%
Non Prescription Drug
19%
Prescription Medication
25%
Prevalence
9%
Randomized Clinical Trial
28%
Rosuvastatin
6%
Statin (Protein)
19%
Systemic Mycosis
12%
Tablet
19%
Therapeutic Drug Monitoring
19%
Vancomycin
19%
Virus Transmission
9%
Withdrawal Syndrome
6%
Nursing and Health Professions
Adverse Drug Reaction
19%
Booster Dose
19%
Cholinergic Receptor Blocking Agent
21%
Cigarette Filter
6%
Clinical Outcome
10%
COVID-19
19%
Cross-Sectional Study
86%
Deprescribing
19%
Drug Use
19%
Dyspnea
6%
Exposure to Violence
6%
Health Belief Model
19%
Health Care Personnel
9%
Household
19%
Logistic Regression Analysis
14%
Multiple Linear Regression Analysis
19%
Non Prescription Drug
19%
Odds Ratio
10%
Pilot Study
10%
Potentially Inappropriate Medication
19%
Power Analysis
6%
Primary Medical Care
19%
Public Health
9%
Safety Procedure
6%
Study Participant
19%
Therapeutic Drug Monitoring
19%
Thorax Pain
12%
Treatment Duration
19%
University Student
19%
Vancomycin
19%
Verbal Hostility
6%
Medicine and Dentistry
Adverse Event
12%
Arm
9%
Booster Dose
19%
COVID-19
19%
Cross Sectional Study
28%
FDA Adverse Event Reporting System
19%
Health Belief Model
19%
Ixazomib
5%
Medication Compliance
9%
Multiple Myeloma
19%
Non Prescription Drug
19%
Parasympatholytic
40%
Primary Outcome
5%
Randomized Clinical Trials
19%
Therapeutic Drug Monitoring
19%
University Student
19%
Vancomycin
19%
